Myopia, or short-sightedness, is an eye condition where distant objects appear blurry due to improper light focusing on the retina. While there is no cure, glasses or contact lenses can help.
Recent studies highlight Atropine 0.01% eye drops as an effective myopia treatment to decelerate progression in children. Originally, Atropine 1% is utilised for pupil dilation during eye exams. However, the myopia treatment uses a concentration of 100 times weaker. The exact way Atropine 0.01% hinders myopia progression remains uncertain, but international studies report high success rates. Notably, side effects, less frequent than the clinical dose, can include minor irritation, light sensitivity, and dilated pupils.
This treatment is not a myopia cure but aims to decelerate its advancement. It is essential to wear glasses and administer the drops nightly consistently. There’s no absolute assurance of its efficacy; missed doses might compromise the treatment.